Clinical Trials Browser

Genetic Testing × 1 year × Clear all

NCT06058377 2026-04-16

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Phase 3 Recruiting

Anatomic Stage II Breast Cancer AJCC v8

NCT06008392 2026-04-07

INTERCEPTioN

Neoplasms

NCT06632977 2026-04-07

PREDICT

Phase 2 Recruiting

Prostatic Neoplasms

NCT07091617 2026-04-07

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Phase NA Recruiting

Pyloric Stenosis, Hypertrophic

NCT04475640 2026-04-02

Cancer Genetic Testing in Ethnic Populations

Phase NA Recruiting

Brain Neoplasms, Breast Neoplasms, Neoplasms, Unknown Primary

NCT04354675 2026-03-31

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT07498829 2026-03-27

PROTECT-C

Phase NA Recruiting

Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT03233191 2026-03-23

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

Phase 3 Active not recruiting

108,508 enrolled

Breast Screening

NCT03897374 2026-03-19

STOP-Cancer

120,000 enrolled

Early Detection of Cancer

NCT01334021 2026-03-09

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Phase 2 Active not recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT01772771 2026-03-03

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

12,000 enrolled

CNSDermatologicOther hematologic neoplasmSarcoma

Glioma, Melanoma, Sarcoma, Hematologic Neoplasms

NCT05028621 2026-02-20

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Phase NA Suspended

LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

NCT05694559 2026-02-19

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

Phase NA Recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07377006 2026-02-18

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07412028 2026-02-17

ANDROLIPO

Phase NA Not yet recruiting

Polycystic Ovary Syndrome, Lipodystrophy, Familial Partial

NCT04254133 2026-01-30

GIFTS

Enrolling by invitation

Prostatic Neoplasms

NCT06569316 2026-01-29

Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)

Phase NA Recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT04494945 2026-01-23

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Phase NA Recruiting

27,500 enrolled

BreastGastrointestinalGynecologic

Carcinoma, Intraductal, Noninfiltrating, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

NCT06574620 2026-01-16

ACCELERATE

Phase NA Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Phase NA Recruiting

LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

NCT05868486 2026-01-02

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

Phase EARLY_PHASE1 Active not recruiting

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT04763980 2025-12-31

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Phase NA Recruiting

Prostatic Neoplasms

NCT06744595 2025-12-12

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

Phase NA Enrolling by invitation

Gastrointestinal

Pancreatic Neoplasms

NCT04447703 2025-12-02

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Phase NA Completed

Prostatic Neoplasms

NCT02620852 2025-11-25

WISDOM

Phase NA Recruiting

100,000 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT03731845 2025-11-20

ESIGON

Phase NA Active not recruiting

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT05649072 2025-11-19

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Phase NA Recruiting

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT03160274 2025-10-15

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

CNSEndocrineGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms

NCT03460483 2025-10-03

OPTEC

Phase NA Completed

GastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

NCT03503097 2025-10-01

GENTleMEN

Neoplasm Metastasis, Prostatic Neoplasms

NCT07143487 2025-09-16

Family Communications After Genetic Testing

Phase NA Not yet recruiting

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03765736 2025-08-29

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

199 enrolled 8 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT03694483 2025-08-22

Prostasomes as Diagnostic Tool for Prostate Cancer Detection

Prostatic Neoplasms

NCT05676099 2025-07-08

TSC Biosample Repository and Natural History Database

Tuberous Sclerosis, Lymphangioleiomyomatosis